SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Gujarat Themis Biosyn starts production in Fermentation Block at Vapi facility

18 Oct 2025 Evaluate

Gujarat Themis Biosyn has completed the expansion of its Fermentation Block at its manufacturing facilities at Vapi, Gujarat. The first batch of commercial production of Rifamycin-S and Rifamycin-O has commenced on October 18, 2025. 

With this expansion, the overall fermentation capacity of the company has increased from 450 KL to 990 KL. This will further strengthen the company’s manufacturing capabilities to produce multiple fermentation products. With this capacity expansion, the company is in a strong position to capitalise on the significant growth opportunities in the fermentation segment.

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company.

Guj. Themis Biosyn Share Price

319.45 15.45 (5.08%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×